College President James Freedman has now completed a six-month series of chemotherapy treatments for non-Hodgkin's lymphoma, diagnosed last April. During this time he has kept the College informed of his condition, continued his daily duties as president and in doing so shown his selfless dedication to the Dartmouth community. Next term he begins a six-month sabbatical, agreed upon by the Board of Trustees last winter.
Freedman's seven years of outstanding leadership have furthered the College's intellectual atmosphere and academic reputation and earned him this respite. The Dartmouth wishes Freedman a pleasant and relaxing sabbatical and looks forward to his return.
